The Flex system, originally cleared in 2015 for transoral applications, is now available for robot-assisted visualization in general surgical, gynecological and thoracic procedures.
Medrobotics Corp.'s Flex robotic imaging system is now US FDA-cleared for transabdominal and transthoracic access for general surgical, gynecological and thoracic procedures.
Medrobotics says the new 510(k) clearance, announced on Jan. 22, makes Flex the "world’s first and only flexible transabdominal and transthoracic robotic scope [and] reaffirms the company’s progress to develop...
Roche aims to grow its diagnostics sales by mid to high single digits, said CEO of Roche Diagnostics Matt Sause. The company unveiled the Axelios synthesis and sequencing solution and discussed its “long-term commitment” to China, as well as its business strategy for the next five years.
The FDA plans to announce class II status for four new device types, including tests for the Zika virus and genetic condition Fragile X. This follows earlier announcements and highlights a trend toward diagnostic classifications. The classifications are considered deregulatory, meaning they will hel
Medtech Insight spoke with Hubert Martens, CEO of Netherlands-based neuromodulation company Salvia Bioelectronics, about the company’s innovative implant for treating chronic migraines, ongoing clinical trials and plans for US clinical trials and commercialization.
